PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Approved cancer drug potentially could help treat diabetes, Stanford researchers find

2013-09-16
(Press-News.org) STANFORD, Calif. — A pair of studies by researchers at the Stanford University School of Medicine has identified a molecular pathway — a series of interaction among proteins — involved in the development of diabetes. Furthermore, they have found that a drug already approved for use in humans can regulate the pathway.

The findings will be published online Sept. 15 in two articles in Nature Medicine.

The studies, done in mice, identify a previously unexpected link between a low-oxygen condition called hypoxia and the ability of cells in the liver to respond to insulin. The drug, aflibercept (marketed as Eylea or Zaltrap), is used to treat metastatic colorectal cancer and a form of macular degeneration. Aflibercept is a member of a family of proteins that inhibit the vascular endothelial growth factor, or VEGF, pathway. It works by blocking the growth of the blood vessels into tumors and starving them of oxygen.

The lab of Calvin Kuo, MD, PhD, professor of medicine, identified a series of protein interactions that link VEGF inhibitors and blood glucose levels. "We were surprised to find that this drug currently used in patients for cancer treatment had beneficial effects on diabetes in laboratory mice and could, potentially, in humans," said Kuo, senior author of one of the Nature Medicine papers.

Amato Giaccia, PhD, the Jack, Lulu and Sam Willson Professor of Cancer Biology, is senior author of the other paper. "Proteins involved in this pathway could also be targeted for the development of new diabetes therapies," said Giaccia, who also is a professor and director of radiation oncology. His laboratory has identified a protein called PhD3 that could be a particularly attractive target.

The lead author of the Giaccia paper is Cullen Taniguchi MD, PhD, a radiation oncology resident at Stanford; former graduate students Kevin Wei, MD, PhD, and Lisa McGinnis, MD, PhD, and postdoctoral scholar Stephanie Piecewicz, PhD, are lead authors of the Kuo paper.

Together, the studies explain an observation made several years ago by Kuo and his lab members that VEGF inhibitors, such as aflibercept, could lower blood glucose levels in mice. There have been intriguing hints that these inhibitors could function in a similar way in humans, but human studies have not been formally conducted.

"Anecdotally, there have been reports that diabetic patients who have been prescribed VEGF inhibitors to treat their cancer are better able to control their diabetes," Kuo said.

The liver is commonly known as the organ responsible for removing toxins from our blood. But it also serves as the body's energy warehouse. After a meal, blood glucose levels rise and insulin triggers cells in the liver to squirrel away the glucose in long, branching chains of a substance called glycogen (imagine an ever-growing Lego structure, where each block is a glucose molecule). When we are asleep or fasting, the liver breaks down that Lego structure unit by unit to deliver glucose into the blood for cells to use as an energy source until the next meal.

When this process goes awry, blood glucose levels can become dangerously high. This can happen when the body either can't make insulin (in the case of type-1, or juvenile, diabetes) or when it can't respond appropriately to the insulin the body does make (type-2 diabetes).

The liver's critical function requires that most of its cells have ready access to blood, which carries both glucose and oxygen. Oxygen diffuses as a gradient outward from blood vessels; those cells that are more removed have less oxygen and can become hypoxic. Hypoxic cells naturally produce certain proteins to enable them to live and function under these more severe conditions.

Wei, McGinnis and Piecewicz, in Kuo's lab, found that one protein induced by hypoxia, HIF-2alpha, activates the expression of insulin receptor substrate 2. IRS2 enhances the ability of the cells to respond to insulin. Treatment of normal and diabetic laboratory mice with a variety of VEGF inhibitors, including aflibercept, causes regression of blood vessels and increases the number of hypoxic cells in the liver. As a result, HIF-2alpha levels increase, IRS2 expression rises and the animals become better able to tolerate increases in blood-glucose levels.

The researchers found that deletion of HIF-2alpha blocked the effect of the VEGF inhibitors, while liver-specific induction of HIF-2alpha expression also significantly improved the animals' glucose tolerance.

"Much work remains to translate these mouse studies to human patients, but it will be interesting to explore VEGF inhibitors or drugs that can stabilize HIF-2alpha, such as prolyl hydroxylase inhibitors, for diabetes treatment, possibly in combination with pre-existing therapies to minimize toxicities," Kuo said.

Taniguchi, in Giaccia's lab, focused on the biology of HIF-2alpha. He and his colleagues found that blocking the expression of a protein called Phd3 specifically taps into the pathway identified by the Kuo group, stabilizing the HIF-2alpha protein and prolonging its effect on IRS2 expression. Laboratory mice missing Phd3 are more sensitive to insulin and exhibit improved glucose tolerance.

The specificity of the effect of Phd3 on HIF-2alpha is important. Because it doesn't appear to regulate other proteins in the HIF family in the liver, it's possible a diabetes treatment could be designed that would avoid unwanted or dangerous side effects that could occur by blocking the production of a more broadly acting protein.

"Targeting the Phd3/HIF-2 pathway represents a new therapeutic approach for the treatment of diabetes with little toxicity," said Giaccia. "These studies indicate that Phd specific inhibitors, especially Phd3, should be more widely developed for clinical development."

###

Additional Stanford authors of the papers were research assistant David Kuo; basic life sciences research associates Jenny Yuan and Mario Vallon; assistant professor of medicine Justin Annes, MD, PhD; and postdoctoral scholars Elizabeth Finger, PhD, Colleen Wu, PhD, Anh Diep, VMD, and Edward LaGory, PhD.

Funding for the studies was provided by the National Institutes of Health (grants R01HL074267, R01NS064517, R01CA158528, 1R01HL074267, RO1DK043748, P60DK020593, U24DK059637 CA67166 and CA88480); the National Cancer Institute (grant CA121940); Radiological Society of North America Resident Research Grants; the Canadian Institutes of Health and Research; the National Institute of General Medical Sciences (grants GM104936 and GM007365); the Sydney Frank Foundation; Stanford's Medical Scientist Training Program; and Stanford training-program grants in comparative animal medicine, cardiovascular medicine, molecular and cellular immunobiology, and molecular endocrinology.

Regeneron Pharmaceuticals, Sanofi and Genentech provided reagents for the Kuo study. Three co-authors of the Kuo study are employees at Regeneron, which manufactures aflibercept.

The Stanford University School of Medicine consistently ranks among the nation's top medical schools, integrating research, medical education, patient care and community service. For more news about the school, please visit http://mednews.stanford.edu. The medical school is part of Stanford Medicine, which includes Stanford Hospital & Clinics and Lucile Packard Children's Hospital. For information about all three, please visit http://stanfordmedicine.org/about/news.html.

Print media contact: Krista Conger at (650) 725-5371 (kristac@stanford.edu)
Broadcast media contact: M.A. Malone at (650) 723-6912 (mamalone@stanford.edu)

END



ELSE PRESS RELEASES FROM THIS DATE:

Subduction channel processes: New progress in plate tectonic theory

2013-09-16
The plate tectonic theory has been primarily developed in three stages. (1) From continental drift and seafloor spreading to oceanic subduction, laying a physical foundation of the plate tectonic theory. This was achieved by the recognitions that continents would be assembled to build a supercontinent Pangea with subsequent breakup to yield the present configuration, lithospheric plates buoyantly move on the asthenospheric mantle, and oceanic crust is subducted along trenches into the mantle. (2) From oceanic subduction to continental subduction and collision orogeny, with ...

Study shows projected climate change in West Africa not likely to worsen malaria situation

2013-09-16
CAMBRIDGE, MA -- As public-health officials continue to fight malaria in sub-Saharan Africa, researchers are trying to predict how climate change will impact the disease, which infected an estimated 219 million people in 2010 and is the fifth leading cause of death worldwide among children under age 5. But projections of future malaria infection have been hampered by wide variation in rainfall predictions for the region and lack of a malaria-transmission model that adequately describes the effects of local rainfall on mosquitoes, which breed and mature in ephemeral pools ...

Diminishing fear vicariously by watching others

2013-09-16
Phobias — whether it's fear of spiders, clowns, or small spaces — are common and can be difficult to treat. New research suggests that watching someone else safely interact with the supposedly harmful object can help to extinguish these conditioned fear responses, and prevent them from resurfacing later on. The research, published in Psychological Science, a journal of the Association for Psychological Science, indicates that this type of vicarious social learning may be more effective than direct personal experience in extinguishing fear responses. "Information about ...

Sharp rise in opioid drugs prescribed for non-cancer pain, reports study in Medical Care

2013-09-16
Philadelphia, Pa. (September 13, 2013) – Prescribing of strong opioid medications for non-cancer pain in the United States has nearly doubled over the past decade, reports a study in the October issue of Medical Care, published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health. At the same time, prescribing of non-opioid pain relievers has been stable or declined, according to the new research by Dr G. Caleb Alexander of Johns Hopkins Bloomberg School of Public Health, Baltimore, and colleagues. Dr Alexander comments, "There is an epidemic of prescription ...

Several common differentially expressed genes between Kashin-Beck disease and Keshan disease

2013-09-15
Kashin-Beck disease (KBD) and Keshan disease (KD) are major endemic diseases in China. Postgraduate Xi Wang et al., under the guidance of Professor Xiong Guo from the Institute of Endemic Diseases of the Faculty of Public Health, Medicine College of Xi'an Jiaotong University, Key Laboratory of Environment and Gene Related Diseases in Ministry of Education, Key Laboratory of Trace Elements and Endemic Diseases of Health Ministry, set out to tackle these two endemic diseases. After several years of innovative research, they have made significant progress in determining the ...

Hypertension researcher encourages colleagues to expand their focus

2013-09-14
Augusta, Ga. – Dr. David Pollock has a simple message for fellow hypertension researchers: think endothelin. In a country where better than 30 percent of adults have high blood pressure and 50-75 percent of those have salt-sensitive hypertension, he believes the powerful endothelin system, which helps the body eliminate salt, should not be essentially ignored. However, the research and clinical world focus on suppressing a better-known system, which prompts the body to hold onto salt, said Pollock, Chief of the Section of Experimental Medicine at the Medical College ...

Sleep better, look better? New research says yes

2013-09-14
ANN ARBOR, Mich. — Getting treatment for a common sleep problem may do more than help you sleep better – it may help you look better over the long term, too, according to a new research study from the University of Michigan Health System and Michigan Technological University. The findings aren't just about "looking sleepy" after a late night, or being bright-eyed after a good night's rest. It's the first time researchers have shown specific improvement in facial appearance after at-home treatment for sleep apnea, a condition marked by snoring and breathing interruptions. ...

CPAP therapy provides beauty sleep for people with sleep apnea

2013-09-14
DARIEN, IL – A new study suggests that people with obstructive sleep apnea (OSA) are perceived to appear more alert, more youthful and more attractive after at least two months of continuous positive airway pressure (CPAP) therapy. "This study showed that independent human raters – both medical personnel and members of the community – can perceive improved alertness, attractiveness, and youthfulness in the appearance of sleepy patients with obstructive sleep apnea, after they have been compliant with use of CPAP at home," said lead author and principal investigator Ronald ...

NASA sees Tropical Depression Gabrielle approaching eastern Canada

2013-09-14
Eastern Canada is now expecting some winds and rain from Tropical Depression Gabrielle as it transfers its energy to a cold front. NASA's Aqua satellite captured an infrared image of Gabrielle that showed some very cold cloud top temperatures and strong thunderstorms around its center. The Atmospheric Infrared Sounder instrument called AIRS that flies aboard NASA's Aqua satellite captured an infrared image of Tropical Depression Gabrielle on Sept. 13 at 06:29 UTC/2:29 a.m. EDT. The AIRS image showed a circular area of very high, cold cloud top temperatures surrounding ...

Fish skin immune responses resemble those of the gut, Penn study finds

2013-09-14
Fish skin is unique in that it lacks keratin, the fibrous protein found in mammalian skin that provides a barrier against the environment. Instead, the epithelial cells of fish skin are in direct contact with the immediate environment: water. Similarly, the epithelial cells that line the gastrointestinal tract are also in direct contact with their immediate milieu. "I like to think of fish as an open gut swimming," said J. Oriol Sunyer, a professor in the the Department of Pathobiology of the University of Pennsylvania's School of Veterinary Medicine. Building on this ...

LAST 30 PRESS RELEASES:

Study tracks chromium chemistry in irradiated molten salts

Scientists: the beautiful game is a silver bullet for global health

Being physically active, even just a couple of days a week, may be key to better health

High-fat diet promote breast cancer metastasis in animal models

A router for photons

Nurses and AI collaborate to save lives, reduce hospital stays

Multi-resistance in bacteria predicted by AI model

Tinker Tots: A citizen science project to explore ethical dilemmas in embryo selection

Sensing sickness

Cost to build multifamily housing in California more than twice as high as in Texas

Program takes aim at drinking, unsafe sex, and sexual assault on college campuses

Inability to pay for healthcare reaches record high in U.S.

Science ‘storytelling’ urgently needed amid climate and biodiversity crisis

KAIST Develops Retinal Therapy to Restore Lost Vision​

Adipocyte-hepatocyte signaling mechanism uncovered in endoplasmic reticulum stress response

Mammals were adapting from life in the trees to living on the ground before dinosaur-killing asteroid

Low LDL cholesterol levels linked to reduced risk of dementia

Thickening of the eye’s retina associated with greater risk and severity of postoperative delirium in older patients

Almost one in ten people surveyed report having been harmed by the NHS in the last three years

Enhancing light control with complex frequency excitations

New research finds novel drug target for acute myeloid leukemia, bringing hope for cancer patients

New insight into factors associated with a common disease among dogs and humans

Illuminating single atoms for sustainable propylene production

New study finds Rocky Mountain snow contamination

Study examines lactation in critically ill patients

UVA Engineering Dean Jennifer West earns AIMBE’s 2025 Pierre Galletti Award

Doubling down on metasurfaces

New Cedars-Sinai study shows how specialized diet can improve gut disorders

Making moves and hitting the breaks: Owl journeys surprise researchers in western Montana

PKU Scientists simulate the origin and evolution of the North Atlantic Oscillation

[Press-News.org] Approved cancer drug potentially could help treat diabetes, Stanford researchers find